Benefit-risk assessment of interferon-b therapy for relapsing multiple sclerosis

Author: Francis Gordon  

Publisher: Informa Healthcare

ISSN: 1474-0338

Source: Expert Opinion on Drug Safety, Vol.3, Iss.4, 2004-07, pp. : 289-303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract